Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes

Funding: We thank to the at Laboratório de Biomedicina Mitocondrial e Teranóstica, Centro de Neurociências e Biologia Celular for the assistance with RNA integrity analysis. We thank the Serviço de Anatomia Patológica, Coimbra University Hospital, especially Ilda Simões, for the support with histolo...

Full description

Bibliographic Details
Main Author: Tavares, G. (author)
Other Authors: Marques, D. (author), Barra, C. (author), Rosendo-Silva, D. (author), Costa, A. (author), Rodrigues, T. (author), Gasparini, P. (author), Melo, B. F. (author), Sacramento, J. F. (author), Seiça, R. (author), Conde, S. V. (author), Matafome, P. (author)
Format: article
Language:eng
Published: 2021
Subjects:
Adipose tissue
Bromocriptine
D2 dopamine receptor
Dopamine
Liver
Obesity
Type 2 diabetes
Molecular Biology
Cell Biology
SDG 3 - Good Health and Well-being
Online Access:http://hdl.handle.net/10362/119578
Country:Portugal
Oai:oai:run.unl.pt:10362/119578

Internet

http://hdl.handle.net/10362/119578

Similar Items